# Myeloid-specific knockout of Notch-1 inhibits MyD88- and TRIF-mediated TLR signaling pathways by regulating oxidative stress-SHP2 axis, thus restraining aneurysm progression

**Authors:** Yu Li, Ailin Guo, Jianlei Liu, Lijuan Tang, Lide Su, Zonghong Liu

PMC · DOI: 10.18632/aging.205392 · Aging (Albany NY) · 2024-01-26

## TL;DR

Disabling Notch-1 in myeloid cells reduces aneurysm progression by lowering inflammation and oxidative stress through the SHP2 pathway.

## Contribution

This study reveals a novel mechanism by which Notch-1 regulates aneurysm progression via oxidative stress and SHP2 in myeloid cells.

## Key findings

- Myeloid-specific knockout of Notch-1 reduced aneurysm size, macrophage infiltration, and oxidative stress in mice.
- Notch-1 knockout increased SHP2 levels and decreased TLR signaling and inflammatory cytokines in aneurysm tissues.
- Macrophage phagocytic capacity was enhanced following Notch-1 knockout via the SHP2 signaling pathway.

## Abstract

Objective: Notch-1 is a signal regulatory protein with extensive effects in myeloid cells, but its role in aneurysms remains to be fully clarified. In this study, therefore, the aneurysm mouse model with myeloid-specific knockout of Notch-1 was established to observe the role of Notch-1 in aneurysm progression.

Methods and Results: The effect of Notch-1 was assessed by pathological staining and Western blotting. It was found that after myeloid-specific knockout of Notch-1 in the aneurysm mouse model, the area of aneurysms and the macrophage infiltration were significantly reduced, the damage to arterial elastic plates was significantly relieved, and the oxidative stress level significantly declined. The results of Western blotting showed that after myeloid-specific knockout of Notch-1, the levels of oxidative stress-related proteins p22 and p47 in aneurysm tissues significantly declined, accompanied by a significant increase in the protein level of Src homology 2 domain-containing tyrosine phosphatase-2 (SHP2). In addition, the levels of phosphorylated myeloid differential protein-88 (MyD88), TIR domain-containing adaptor-inducing interferon-β (TRIF) and nuclear factor-κB (NF-κB), and inflammatory cytokines interferon-γ (IFN-γ), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) also significantly decreased after myeloid-specific knockout of Notch-1. Following myeloid-specific knockout of Notch-1, the phagocytic capacity of macrophages was enhanced by promoting the SHP2 signaling pathway.

Conclusion: Notch-1 in monocytes/macrophages can activate the Toll-like receptor (TLR)-mediated inflammatory and stress responses by activating oxidative stress and inhibiting the SHP2 protein expression, thus facilitating aneurysm progression.

## Linked entities

- **Genes:** NOTCH1 (notch receptor 1) [NCBI Gene 4851], MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615], TRIM69 (tripartite motif containing 69) [NCBI Gene 140691], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], PTPN11 (protein tyrosine phosphatase non-receptor type 11) [NCBI Gene 5781], DYNC1H1 (dynein cytoplasmic 1 heavy chain 1) [NCBI Gene 1778], ING1 (inhibitor of growth family member 1) [NCBI Gene 3621], IFNG (interferon gamma) [NCBI Gene 3458], IL1B (interleukin 1 beta) [NCBI Gene 3553], TNF (tumor necrosis factor) [NCBI Gene 7124]
- **Proteins:** NOTCH1 (notch receptor 1), MYD88 (MYD88 innate immune signal transduction adaptor), TRIM69 (tripartite motif containing 69), NFKB1 (nuclear factor kappa B subunit 1), PTPN11 (protein tyrosine phosphatase non-receptor type 11), DYNC1H1 (dynein cytoplasmic 1 heavy chain 1), ING1 (inhibitor of growth family member 1), IFNG (interferon gamma), IL1B (interleukin 1 beta), TNF (tumor necrosis factor)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Notch1 (notch 1) [NCBI Gene 18128] {aka 9930111A19Rik, Mis6, N1, Tan1, lin-12}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Ticam1 (TIR domain containing adaptor molecule 1) [NCBI Gene 106759] {aka TICAM-1, TRIF}, Ptpn11 (protein tyrosine phosphatase, non-receptor type 11) [NCBI Gene 19247] {aka 2700084A17Rik, PTP1D, PTP2C, SAP-2, SH-PTP2, SH-PTP3}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Nsfl1c (NSFL1 (p97) cofactor (p47)) [NCBI Gene 386649] {aka Munc-18c, Stxbp3a, p47}, Dync1h1 (dynein cytoplasmic 1 heavy chain 1) [NCBI Gene 13424] {aka 9930018I23Rik, DHC1, DHC1a, DNCL, Dnchc1, Dnec1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}
- **Diseases:** inflammatory (MESH:D007249), aneurysm (MESH:D000783)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10866402/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10866402/full.md

## References

27 references — full list in the complete paper: https://tomesphere.com/paper/PMC10866402/full.md

---
Source: https://tomesphere.com/paper/PMC10866402